Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With Ultrasound for Sonodynamic Therapy (SDT) in Patients With Ne… Ended

2023-509238-20-00 High grade glioma 4 2025-11-21
A Phase 1 Study of ATV-1601, in Patients with Advanced Cancer that have AKT1 E17K Mutations Ended

2025-521480-12-00 Advanced solid tumors, Breast Cancer 1 2025-10-22
A First-in-human study to learn how safe the study drug BAY2965501 is, find the best dose (single drug & combination), how it affects the bo… Ended

2023-507905-33-00 Advanced solid tumors 1 2025-09-30
A Study to Learn if Multiple Doses of the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine PF-072… Ended

2025-522331-34-00 locally advanced or metastatic ER+/HER2- breast cancer 3 2025-09-15
A Study to Learn If The Study Medicine Called Fluconazole Changes How the Body Processes The Other Study Medicine PF-07248144 Ended

2025-521924-31-00 locally advanced or metastatic HR+/HER2- breast cancer 3 2025-08-20
A Phase 1 study to evaluate the metabolism of [14C]PF-07104091 in healthy adult male participants Ended

2024-518696-65-00 (HR) -positive human epidermal growth factor receptor 2 3 2025-08-12
A study to investigate safety of INT2104 infusions in participants aged 18 years of age and older who have B-cell cancers that came back aft… Ended

2023-509132-26-00 Refractory/Relapsing B-Cell Malignancies 1 2025-08-08
A trial to learn how safe saruparib is and how well it works in people with advanced ovarian cancer Ended

2024-519044-32-00 Advanced/Recurrent Ovarian cancer 9 2025-08-06
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Ruxolit… Ended

2024-519801-36-00 Myelofibrosis, polycythemia vera, acute and chronic gra 2 2025-07-14
A Study of PF-08046031 in Adults With Advanced Melanoma and Other Solid Tumors Ended

2024-514745-10-00 Melanoma (or) malignant melanoma Non-small cell lung ca 1 2025-06-23
A trial to learn how saruparib works and how safe it is in the bodies of adults with advanced solid tumors Ended

2024-513692-41-00 advanced solid malignancies 3 2025-06-11
A Phase 1a/1b Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of BG-60366 in Patien… Ended

2024-517322-26-00 EGFR-Mutant Non-Small Cell Lung Cancer 1 2025-06-06
A study to learn about the study medicine called PF-08046032 in people with advanced cancers. Ended

2024-517756-35-00 Advanced lymphomas (classic Hodgkin lymphoma [cHL], per 3 2025-05-28
A Study to Investigate the Safety and Effectiveness of RO7759065 in Combination with Atezolizumab in Participants with Locally Advanced or M… Ended

2024-513391-17-00 Locally Advanced or Metastatic Solid Tumors 1 2025-05-27
A Phase 1a/1b Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of the DG… Ended

2023-503996-38-00 Advanced or metastatic solid tumors 1 2025-05-21
A Phase 2 Study of PRT3789 in Combination with Pembrolizumab in Patients with Advanced or Metastatic Solid Tumors with a SMARCA4 Mutation Ended

2024-516889-11-00 non-small cell lung cancer (NSCLC) 4 2025-05-21
A Phase 1 Study of JNJ-87562761 in Relapsed/Refractory Multiple Myeloma Ended

2024-513439-25-00 Relapsed/Refractory Multiple Myeloma 1 2025-04-30
A trial to learn how safe AZD0022 is, how well it works, and how it moves throughout the body over time in adults with tumors that have a KR… Ended

2024-516699-14-00 Non Small Cell Lung Cancer Colorectal Cancer Pancreatic 7 2025-04-23
Phase 1 trial of LAVA-1266, a CD123-targeting bispecific Vγ9Vδ2-T cell engager, in patients with CD123 positive relapsed/refractory (R/R) ac… Ended

2024-518831-12-00 CD123 positive R/R AML and intermediate risk, high risk 1 2025-04-15
A dosimetry study of lutetium (177Lu) rhPSMA-10.1 and lutetium (177Lu) vipivotide tetraxetan (Pluvicto®) in patients with non-curative metas… Ended

2024-515264-31-00 PSMA-positive non-curative metastatic castration-resist 3 2025-04-15
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose crossover bioequivalence study comparing Enzalutam… Ended

2024-518209-16-00 Prostate cancer 2 2025-04-14
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose crossover bioequivalence study comparing Enzalutam… Ended

2024-518211-20-00 Prostate cancer 2 2025-04-14
A study to test Aumolertinib in European participants with genetically linked advanced Lung Cancer Ended

2024-519618-29-00 Non-Small Cell Lung Cancer (NSCLC) with Epidermal Growt 3 2025-04-08
A Study to Learn How a Tablet Compared with an IV Infusion of the Study Medicine Called Vepdegestrant is Taken up into the Blood in Healthy … Ended

2024-518134-92-00 ER+/HER2- breast cancer 3 2025-04-02